المؤلفون: Lore Decoster, Karin Pat, Anne Sibille, Frederic Clinckart, Sofie Joris, Stéphane Holbrechts, Marc Lambrechts, Frederique Bustin, Denis Schallier, Laurence Jacqmin, Wim Demey, Hassan Rezaei Kalantari, Veerle Surmont, Koen Deschepper, Thierry Pieters, Jean-Charles Goeminne

المساهمون: Medical Oncology, Clinical sciences, Laboratory of Molecular and Medical Oncology, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'oncologie médicale

المصدر: Journal of geriatric oncology, Vol. 11, no. 5, p. 796-801 (2019)

مصطلحات موضوعية: Compassionate Use Trials, medicine.medical_specialty, Lung Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Non-small cell lung cancer, Belgium, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, older, Humans, 030212 general & internal medicine, Adverse effect, Lung cancer, neoplasms, non-small cell lung cancer, Aged, Retrospective Studies, Performance status, business.industry, Age Factors, Compassionate Use, Retrospective cohort study, medicine.disease, Older, Nivolumab, Docetaxel, 030220 oncology & carcinogenesis, oncology, Non small cell, Geriatrics and Gerontology, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3684f3713e0b86cfe548b49b9f9c562
https://biblio.vub.ac.be/vubir/real-life-safety-and-effectiveness-of-nivolumab-in-older-patients-with-nonsmall-cell-lung-cancer-results-from-the-belgian-compassionate-use-program(2593922e-5a4d-49ac-b2b8-a9ff594edda4).html